Duke University

Duke’s research, startup’s mobile messaging platform meet in joint venture for patient compliance

A new mobile health startup is bringing together industry and academia to help providers and payers address patient non-compliance. Improved Patient Outcomes Inc. (IPO) is a new joint venture spun around research from Duke University and mobile health technology from Cleveland company CellepathicRx. CellepathicRx designs mobile messaging programs that use reminders, educational messages, motivational messages […]

Pharma

Personalized medicine: A long path, uncertain directions and distant goals

If personalized medicine’s promise isn’t easily understood, Dr. Kristin Newby can readily explain it through her clinical practice. The cardiologist at the Duke University Medical Center in Durham, North Carolina routinely sees patients who have had a heart attack or are at risk for one. But some of them had heart attacks without showing any […]

By Frank Vinluan

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

Pharma

What venture capitalists look for in personalized medicine investments

Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can guide personalized medicine. Bob Kocher, a partner at venture capital firm Venrock, said that these consumer-focused companies have all taken steps toward personalizing their offerings. Personalization increases the value of those offerings and helps the […]

By Frank Vinluan

Pharma

Personalized medicine’s promise and challenges discussed at Duke forum

For those counting, today is day 3,273 since the sequencing of the human genome was completed. Eric Green, director of the National Human Genome Research Institute, is among those counting. Medicine based on genomic information promises new advances for healthcare as technology gives clinicians new tools to make diagnostic and treatment decisions based on a […]

By Frank Vinluan

Devices & Diagnostics

Electrical muscle stimulation medical device zaps March Madness teams

Some of most electrifying March Madness moments actually happen on the sidelines. During timeouts or other breaks in the action, look for trainers affixing electrodes to the area around an athlete’s injured muscle or joint. The wires plug into a small device that sends electrical signals to temporarily relieve pain. “Most of the players just […]

By Frank Vinluan

News

Duke and UNC: Basketball rivals, but global teammates off the court

Duke University visits Chapel Hill tonight to play the University of North Carolina in a men’s college basketball matchup that will keep at least two-thirds of Research Triangle basketball fans riveted tonight. Even basketball observers outside of the Triangle call it the biggest rivalry in sports, or at least in college basketball. But the longtime […]

By Frank Vinluan

Hospitals

Duke prostate cancer test research strikes a musical note

The prostate cancer test to confirm a diagnosis is an uncomfortable medical procedure with an equally awkward name — the transrectal biopsy. This intrusive test uses an ultrasound probe and needle to retrieve a tissue sample for analysis. Even when the biopsy causes no pain, it sparks plenty of patient anxiety. Duke University researchers have […]

By Frank Vinluan

News

Duke gets $37M in AIDS research grants from Gates Foundation

AIDS research efforts at Duke University have landed three grants totaling $37.2 million from the Bill & Melinda Gates Foundation. The grants will fund Duke University Medical Center HIV work in the Collaboration for AIDS Vaccine Discovery (CAVD) program, an international network of scientists working to bring new HIV vaccine candidates into clinical trials. The […]

By Frank Vinluan

News

N.C. Alzheimer’s study aims to find ways to predict, treat the disease earlier

Duke University is partnering with the North Carolina Research Campus in an expansion of an Alzheimer's disease study that aims to find new ways to predict and treat the disease. Research initially began in 2007 to study disease patterns over the long term for patients in the city of Kannapolis, North Carolina, where the N.C. Research Campus is based, as well as surrounding Cabarrus County. Researchers are expanding the "Measurement to Understand the Reclassification of Disease of Cabarrus/Kannapolis" or MURDOCK study to include participants 55 and older who have not been diagnosed with Alzheimer's disease and live in outlying areas surrounding Cabarrus County.

By Frank Vinluan

Health IT

Duke, Durham County land $6M grant for diabetes health IT initiative

Duke University Medical Center is working with Durham County, North Carolina to map diabetes in the community in a new health IT effort to track and manage the disease. Duke and the Durham County Department of Health and Human Services will receive $6.25 million over five years to develop and implement programs to help people […]

By Frank Vinluan

BioPharma

BioLabs Pegasus Park Cultivates Life Science Ecosystem

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.

News

Duke University gets $25M grant to research genetics of epilepsy

Duke University Medical Center has been awarded a $25 million federal grant to research epilepsy in an effort to understand its genetic roots and develop new treatments for the disorder. The National Institute of Neurological Diseases and Stroke, a part of the National Institutes of Health, funded the grant as part of its “Center Without […]

By Frank Vinluan

Health IT

Duke University and Verizon partner on new health IT initiative

Duke University is partnering with Verizon (NYSE:VZ) in a health IT initiative pursuing technologies intended to improve care, expand healthcare access and lower costs. The agreement pairs Duke’s research resources with Verizon Connected Healthcare Solutions, the telecom giant’s healthcare practice group. Duke will make available personnel, including research and project management experts. Intellectual property from […]

By Frank Vinluan

News

Philip Morris buys smokeless nicotine technology from Duke researcher

A smokeless nicotine-delivery system developed by a Duke University researcher is now in the hands of tobacco industry giant Philip Morris International (NYSE:PM). Philip Morris has purchased the patent and global rights to an aerosol nicotine-delivery system developed by Jed Rose, who is director of Duke’s Center for Nicotine and Smoking Cessation Research. Financial terms […]

By Frank Vinluan

News

Duke University research finds cells that target Dengue fever

Duke University researchers have found that cells that play a role in triggering a response to bacteria and pathogens could also have a role in attacking dengue fever, a tropical disease for which there is no vaccine. A Duke research team at the Duke-NUS Graduate Medical School in Singapore studied mast cells in mice. Mast […]

By Frank Vinluan

News

Duke Cancer Institute names St. Jude hospital executive to top post

St. Jude Children’s Research Hospital veteran Dr. Michael Kastan has been named the new executive director of the Duke Cancer Institute. Kastan, a cancer scientist, is currently the director of the Comprehensive Cancer Center at St. Jude in Memphis, Tennessee. He has directed the cancer center since 2004 and under his tenure, St. Jude became […]

By Frank Vinluan

Physicians

OmniLife Health’s Clinical Workflow Solution Focuses on Complex Care

OmniLife Health's initial focus with its complex care coordination platform is organ transplant care.

Health Tech

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI

HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.